<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ariyasingha NM</submitter><funding>Russian Ministry of Science and Higher Education</funding><funding>National Heart, Lung, and Blood Institute (NHLBI) - NIH</funding><funding>Congressionally Directed Medical Research Programs</funding><funding>Directorate for Mathematical and Physical Sciences</funding><funding>NHLBI NIH HHS</funding><funding>Russian Foundation for Basic Research</funding><funding>Russian Science Foundation</funding><funding>Russian Foundation for Basic Research (RFBR)</funding><pagination>13621-13626</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7722203</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(60)</volume><pubmed_abstract>The growing interest in magnetic resonance imaging (MRI) for assessing regional lung function relies on the use of nuclear spin hyperpolarized gas as a contrast agent. The long gas-phase lifetimes of hyperpolarized &lt;sup>129&lt;/sup> Xe make this inhalable contrast agent acceptable for clinical research today despite limitations such as high cost, low throughput of production and challenges of &lt;sup>129&lt;/sup> Xe imaging on clinical MRI scanners, which are normally equipped with proton detection only. We report on low-cost and high-throughput preparation of proton-hyperpolarized diethyl ether, which can be potentially employed for pulmonary imaging with a nontoxic, simple, and sensitive overall strategy using proton detection commonly available on all clinical MRI scanners. Diethyl ether is hype</pubmed_abstract><journal>Chemistry (Weinheim an der Bergstrasse, Germany)</journal><pubmed_title>Parahydrogen-Induced Polarization of Diethyl Ether Anesthetic.</pubmed_title><pmcid>PMC7722203</pmcid><funding_grant_id>AAAA-A16-116121510087-5</funding_grant_id><funding_grant_id>19-13-00172</funding_grant_id><funding_grant_id>19-33-60045</funding_grant_id><funding_grant_id>R21HL154032</funding_grant_id><funding_grant_id>17-54-33037</funding_grant_id><funding_grant_id>W81XWH-15-1-0271</funding_grant_id><funding_grant_id>CHE-1904780</funding_grant_id><funding_grant_id>19-53-12013</funding_grant_id><funding_grant_id>R21 HL154032</funding_grant_id><pubmed_authors>Chukanov NV</pubmed_authors><pubmed_authors>Bukhtiyarov VI</pubmed_authors><pubmed_authors>Joalland B</pubmed_authors><pubmed_authors>Younes HR</pubmed_authors><pubmed_authors>Chekmenev EY</pubmed_authors><pubmed_authors>Ariyasingha NM</pubmed_authors><pubmed_authors>Kovtunov KV</pubmed_authors><pubmed_authors>Gelovani JG</pubmed_authors><pubmed_authors>Koptyug IV</pubmed_authors><pubmed_authors>Salnikov OG</pubmed_authors><pubmed_authors>Kovtunova LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Parahydrogen-Induced Polarization of Diethyl Ether Anesthetic.</name><description>The growing interest in magnetic resonance imaging (MRI) for assessing regional lung function relies on the use of nuclear spin hyperpolarized gas as a contrast agent. The long gas-phase lifetimes of hyperpolarized &lt;sup>129&lt;/sup> Xe make this inhalable contrast agent acceptable for clinical research today despite limitations such as high cost, low throughput of production and challenges of &lt;sup>129&lt;/sup> Xe imaging on clinical MRI scanners, which are normally equipped with proton detection only. We report on low-cost and high-throughput preparation of proton-hyperpolarized diethyl ether, which can be potentially employed for pulmonary imaging with a nontoxic, simple, and sensitive overall strategy using proton detection commonly available on all clinical MRI scanners. Diethyl ether is hype</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-04T01:43:01.212Z</modification><creation>2025-04-04T01:43:01.212Z</creation></dates><accession>S-EPMC7722203</accession><cross_references><pubmed>32667687</pubmed><doi>10.1002/chem.202002528</doi></cross_references></HashMap>